Growth Metrics

Profound Medical (PROF) Receivables - Net (2018 - 2026)

Profound Medical has reported Receivables - Net over the past 8 years, most recently at $7.6 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 8.18% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $7.6 million, up 8.18%, while the annual FY2025 figure was $7.6 million, 8.18% up from the prior year.
  • Receivables - Net for Q4 2025 was $7.6 million at Profound Medical, down from $8.2 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $8.2 million in Q3 2025 and troughed at $4.1 million in Q2 2025.
  • A 5-year average of $6.2 million and a median of $6.3 million in 2022 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: grew 26.02% in 2022 and later plummeted 39.03% in 2025.
  • Year by year, Receivables - Net stood at $5.0 million in 2021, then increased by 26.02% to $6.3 million in 2022, then grew by 14.88% to $7.3 million in 2023, then fell by 3.33% to $7.0 million in 2024, then rose by 8.18% to $7.6 million in 2025.
  • Business Quant data shows Receivables - Net for PROF at $7.6 million in Q4 2025, $8.2 million in Q3 2025, and $4.1 million in Q2 2025.